Bubble-Assisted Ultrasound: Application in Immunotherapy and Vaccination.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1007/978-3-319-22536-4_14PMID 26486342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug delivery across the blood–brain barrier using focused ultrasound

  2014cited by this paper
• Melanoma immunotherapy

  2014cited by this paper
• Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system

  2014cited by this paper
• Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

  2013cited by this paper
• The blood-brain barrier: an engineering perspective

  2013cited by this paper
• Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood–brain barrier divide

  2013cited by this paper
• Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study.

  2013cited by this paper
• Head and neck cancer: from anatomy to biology

  2013cited by this paper
• Irinotecan delivery by microbubble-assisted ultrasound: in vitro validation and a pilot preclinical study.

  2013cited by this paper
• The Melanoma Research Alliance: The Power of Patient Advocacy to Accelerate Research and Novel Therapies

  2013cited by this paper
• In-vivo gene delivery by sonoporation: recent progress and prospects.

  2012cited by this paper
• Current Treatment Options for Metastatic Head and Neck Cancer

  2012cited by this paper
• Genetic cancer vaccines: current status and perspectives

  2012cited by this paper
• Immunotherapy for Alzheimer disease—the challenge of adverse effects

  2012cited by this paper
• Treatment of HER2-positive breast cancer: current status and future perspectives

  2012cited by this paper
• Microbubble Therapy Enhances Anti-tumor Properties of Cisplatin and Cetuximab In Vitro and In Vivo

  2012cited by this paper
• Dendritic cell-based vaccines: barriers and opportunities.

  2012cited by this paper
• Prophylactic immunization with Bubble liposomes and ultrasound-treated dendritic cells provided a four-fold decrease in the frequency of melanoma lung metastasis.

  2012cited by this paper
• Antibody therapy of cancer

  2012cited by this paper
• Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.

  2012cited by this paper
• In vitro and in vivo transfection of primary phagocytes via microbubble-mediated intraphagosomal sonoporation.

  2011cited by this paper
• Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier.

  2011cited by this paper
• Systems neuroscience: The stress of dieting

  2011cited by this paper
• The biology of brain metastases—translation to new therapies

  2011cited by this paper
• Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

  2011cited by this paper
• mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells.

  2011cited by this paper
• Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems.

  2011cited by this paper
• Sonoporation Delivery of Interleukin-27 Gene Therapy Efficiently Reduces Prostate Tumor Cell Growth In Vivo

  2011cited by this paper
• Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure.

  2010cited by this paper
• In vitro gene transfer by electrosonoporation.

  2010cited by this paper
• Radiosensitization of chemotherapy-refractory, locally advanced or locally recurrent breast cancer with trastuzumab: a phase II trial.

  2010cited by this paper
• Electroporation gene therapy preclinical and clinical trials for melanoma.

  2010cited by this paper
• Acoustic microstreaming around a gas bubble.

  2010cited by this paper
• Antibodies Targeted to the Brain with Image-Guided Focused Ultrasound Reduces Amyloid-β Plaque Load in the TgCRND8 Mouse Model of Alzheimer's Disease

  2010cited by this paper
• Gene Transfer: How Can the Biological Barriers Be Overcome?

  2010cited by this paper
• Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy.

  2010cited by this paper
• Advances in understanding of toxicities of treatment for head and neck cancer.

  2009cited by this paper
• Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases.

  2009cited by this paper
• Intracerebroventricular amyloid-β antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice

  2009cited by this paper
• Anti-Aß immunotherapy in Alzheimer's disease; relevance of transgenic mouse studies to clinical trials

  2009cited by this paper
• Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor.

  2008cited by this paper
• Ultrasound mediated delivery of drugs and genes to solid tumors.

  2008cited by this paper
• Mixed results for disease-modification strategies for Alzheimer's disease

  2008cited by this paper
• Ultrasound Enhanced Delivery of Molecular Imaging and Therapeutic Agents in Alzheimer's Disease Mouse Models

  2008cited by this paper
• Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

  2008cited by this paper
• Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: Relevance of Transgenic Mouse Studies to Clinical Trials

  2008cited by this paper
• Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene — a phase I/II clinical protocol

  2007cited by this paper
• Targeted retroviral gene delivery using ultrasound

  2007cited by this paper
• Trastuzumab--mechanism of action and use in clinical practice.

  2007cited by this paper
• Local delivery system of cytotoxic agents to tumors by focused sonoporation

  2007cited by this paper
• Intratumoral injection of IL-12 plasmid DNA – results of a phase I/IB clinical trial

  2007cited by this paper
• Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

  2006cited by this paper
• Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.

  2006cited by this paper
• Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.

  2006cited by this paper
• Sonoporation from jetting cavitation bubbles.

  2006cited by this paper
• Drug penetration in solid tumours

  2006cited by this paper
• Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents

  2005cited by this paper
• Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models.

  2005cited by this paper
• Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma.

  2004cited by this paper
• Detachment and sonoporation of adherent HeLa-cells by shock wave-induced cavitation.

  2003cited by this paper
• Immunogene Therapy of Recurrent Glioblastoma Multiforme with a Liposomally Encapsulated Replication-Incompetent Semliki Forest Virus Vector Carrying the Human Interleukin-12 gene – a phase I/II Clinical Protocol

  2003cited by this paper
• Vaccinology: past achievements, present roadblocks and future promises.

  2003cited by this paper
• Diagnosis and management of central nervous system metastases from breast cancer.

  2003cited by this paper
• Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

  2003cited by this paper
• Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model.

  2003cited by this paper
• Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease.

  2002cited by this paper
• IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.

  2002cited by this paper
• Passage of amyloid β protein antibody across the blood–brain barrier in a mouse model of Alzheimer’s disease

  2002cited by this paper
• Basic Immunology : Functions and Disorders of the Immune System

  2001cited by this paper
• Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.

  2001cited by this paper
• Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease

  2001cited by this paper
• Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

  2000cited by this paper
• Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.

  2000cited by this paper
• Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.

  1990cited by this paper

• Approaches and applications in transdermal and transpulmonary gene drug delivery

  2025cites this paper
• Nanobubbles: An emerging therapeutic paradigm for targeted cancer therapy.

  2025cites this paper
• Enhanced model antigen retention in tissue through topical high-frequency ultrasound treatment

  2024cites this paper
• Recent advances in ultrasound-targeted nanobubbles combined with cancer immunotherapy: Mechanisms, applications, and challenges

  2024cites this paper
• Viability variation of T-cells under ultrasound exposure according to adhesion condition with bubbles

  2023cites this paper
• A Review of Ultrasound-Mediated Checkpoint Inhibitor Immunotherapy.

  2023cites this paper
• Radiation combined with ultrasound and microbubbles: A potential novel strategy for cancer treatment

  2023cites this paper
• Mechanistic Insights and Therapeutic Delivery through Micro/Nanobubble-Assisted Ultrasound

  2022cites this paper
• Sonoporation of Immune Cells: Heterogeneous Impact on Lymphocytes, Monocytes and Granulocytes.

  2022cites this paper
• Microbubble-Assisted Ultrasound for Imaging and Therapy of Melanoma Skin Cancer: A Systematic Review.

  2022cites this paper
• The crosstalk between sonodynamic therapy and autophagy in cancer

  2022cites this paper
• Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting

  2022cites this paper
• Stimuli-responsive drug delivery systems for cancer immunotherapy

  2022cites this paper
• Ultrasound-mediated immune regulation in tumor immunotherapy

  2022cites this paper
• Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

  2021cites this paper
• Synergistic anti-tumor effect of anti-PD-L1 antibody cationic microbubbles for delivery of the miR-34a gene combined with ultrasound on cervical carcinoma.

  2021cites this paper
• Artificial intelligence and guidance of medicine in the bubble

  2021cites this paper
• Synergistic Effects of Acoustics-based Therapy and Immunotherapy in Cancer Treatment

  2021cites this paper
• Exploring Chitosan-Shelled Nanobubbles to Improve HER2+ Immunotherapy Through Dendritic Cells Targeting

  2021cites this paper
• Lipid-based microbubbles and ultrasound for therapeutic application.

  2020cites this paper
• Ultrasonic Transdermal Delivery System with Acid-Base Neutralization-Generated CO2 Microbubble Cavitation.

  2020cites this paper
• Ultrasound Stimulations Induce Prolonged Depolarization and Fast Action Potentials in Leech Neurons

  2020cites this paper
• Ultrasonically and Iontophoretically Enhanced Drug-Delivery System Based on Dissolving Microneedle Patches

  2020cites this paper
• Ultrasound-Responsive Materials for Drug/Gene Delivery

  2020cites this paper
• Ultrasound-Targeted Microbubble Destruction (UTMD) for Localized Drug Delivery into Tumor Tissue

  2019cites this paper
• Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities

  2019cites this paper
• Achieving curative treatment of advanced

  2019cites this paper
• Understanding ultrasound neuromodulation using a computationally efficient and interpretable model of intramembrane cavitation

  2019cites this paper
• Cavitation-threshold Determination and Rheological-parameters Estimation of Albumin-stabilized Nanobubbles

  2018cites this paper
• Ultrasound-mediated microbubble destruction: a new method in cancer immunotherapy

  2018cites this paper
• Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation

  2018cites this paper
• Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring

  2017cites this paper
• Ultrasound-guided drug delivery in cancer

  2017cites this paper